Research-Driven CBD Innovation Since 2020
Clinically tested. Scientifically proven. Trusted by athletes.
Founded on Science, Driven by Results
NextEvo was founded during COVID by former Johnson & Johnson executives with a singular mission: create CBD products that actually work.Our team brought over 25 years of pharmaceutical R&D experience and 30+ patents to develop our proprietary SmartSorb™ technology—a breakthrough water-soluble CBD formula that delivers 6x better absorption and 40x faster onset than traditional oil-based products.
2024: Launching Our Clinical Strength Line
In 2024, we launched our Clinical Strength line featuring:
- 5% CBD Cream - The industry's highest concentration (5000mg per tube)
- 40mg CBD Tablets - Our most powerful systemic absorption formula
Both products are clinically tested and backed by peer-reviewed research from Dr. David Chernoff, MD (Yale/NYU-trained physician with 25 years in biopharma).
David Chernoff, MD
David is a molecular diagnostics and biopharmaceutical industry veteran with over 25 years of global experience.
As Chief Medical Officer for multiple companies including Adamas, Aquinox, Crescendo Bioscience, Schiff Nutrition, and SetPoint Medical, David has played pivotal roles in moving early-stage R&D programs successfully through clinical development and product commercialization and evaluating a broad range of in-licensing opportunities. He has a keen interest in anti-inflammatory science.
David is a graduate of Yale University as well as the New York University Grossman School of Medicine.